PTCT - PTC drops as EU panel declines to recommend Translarna marketing renewal
2024-06-28 07:10:33 ET
More on PTC Therapeutics
- PTC Therapeutics: Riding The Regulatory Rollercoaster With Translarna
- PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts
- PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript
- PTC Therapeutics says FDA lifted partial hold on Huntington's disease program
- PTC Therapeutics announces validation of Sepiapterin European MAA